AstraZeneca: Fascinating Company With Lofty Ambitions - Just Not A Buy Yet
…
78,250€
0,32%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.…
Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors
Astrazeneca (AZN) closed the most recent trading day at $71.93, moving -1.24% from the previous trading session.…
Total Voting Rights
2 June 2025
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds By Reuters
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds…
Danaher Partners With AstraZeneca to Support Precision Medicine
DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient selection and making…
Why Tempus AI Stock Plummeted This Week
Extending the more-than-4% slide that they experienced last week, shares of Tempus AI (NASDAQ: TEM) have suffered an even more…
Danaher in partnership with AstraZeneca for diagnostic tests for precision medicine
…
A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today
Shares of Tempus AI (NASDAQ: TEM) are falling on Wednesday. One of Cathie Woods largest holdings, the companys stock plummeted…
Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy?
Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.…
AZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder Cancer
AstraZeneca wins CHMP nod for Imfinzi combo in muscle-invasive bladder cancer, based on data from the phase III NIAGARA study.…
Why AstraZeneca May Be 2025s Most Underrated Pharma Stock
…
Swedish Business Consortium to build AI Factory with NVIDIA
· AstraZeneca, Ericsson, Saab, SEB and Wallenberg Investments to tap new sovereign AI infrastructure
· NVIDIA to open AI…
AstraZeneca CEO gains shares under performance plan By Investing.com
AstraZeneca CEO gains shares under performance plan…
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Shell, Ocean Power Technologies and Wheeler Real Estate Investment Trust
Visa, AstraZeneca, Shell, Ocean Power Technologies and Wheeler Real Estate Investment Trust are part of the Zacks top Analyst Blog.…